FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050362026> ?p ?o ?g. }

• W2050362026 endingPage "1418" @default.
• W2050362026 startingPage "1413" @default.
• W2050362026 abstract "Proton pump inhibitors (PPIs) are frequently coadministered with calcineurin inhibitors (CNIs) such as tacrolimus (TAC) and cyclosporin A (CSA), to treat or prevent upper gastrointestinal complications in Japanese patients with connective tissue diseases (CTDs). The coadministration of PPIs increases the blood concentration of TAC due to drug interaction. We retrospectively investigated the influence of the coadministration of PPIs and CNIs, as well as the influence of the cytochrome P450 (CYP) 2C19 gene polymorphism status, on the blood concentrations of TAC and CSA in patients with CTDs.Patients treated with TAC (n=35) or CSA (n=30) were enrolled and divided into three groups according to the PPI they received: lansoprazole (LPZ)-combined, rabeprazole (RPZ)-combined, and non-PPI-combined groups. We compared the blood concentrations of TAC or CSA and the incidences of adverse events among the three groups. CYP2C19 gene polymorphisms were also assessed to investigate its influence on the blood concentration of TAC or CSA.LPZ significantly increased the blood concentration of TAC 12 hours after TAC administration (p=0.030 and p=0.003, respectively) and CSA (p=0.047 and p=0.014, respectively) in comparison with RPZ and non-PPI-combined treatment. There were no significant differences in the mean CSA blood concentration two hours after administration in patients with or without PPI treatment, in the incidence of adverse events, or in the CYP2C19 gene polymorphism status among the three groups.Combining agents that are mainly metabolized by CYP3A4 such as LPZ elevates the blood concentrations of TAC and CSA, which could leading to adverse events." @default.
• W2050362026 created "2016-06-24" @default.
• W2050362026 creator A5014785853 @default.
• W2050362026 creator A5025171057 @default.
• W2050362026 creator A5035959084 @default.
• W2050362026 creator A5042491943 @default.
• W2050362026 creator A5073839222 @default.
• W2050362026 creator A5074510658 @default.
• W2050362026 creator A5077131800 @default.
• W2050362026 creator A5080036669 @default.
• W2050362026 creator A5087552309 @default.
• W2050362026 date "2014-01-01" @default.
• W2050362026 modified "2023-10-03" @default.
• W2050362026 title "The Proton Pump Inhibitor Lansoprazole, but not Rabeprazole, the Increased Blood Concentrations of Calcineurin Inhibitors in Japanese Patients with Connective Tissue Diseases" @default.
• W2050362026 cites W1550666015 @default.
• W2050362026 cites W1588904229 @default.
• W2050362026 cites W1986461968 @default.
• W2050362026 cites W2024177850 @default.
• W2050362026 cites W2060854533 @default.
• W2050362026 cites W2073770369 @default.
• W2050362026 cites W2159435181 @default.
• W2050362026 cites W4233519515 @default.
• W2050362026 doi "https://doi.org/10.2169/internalmedicine.53.2394" @default.
• W2050362026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24990333" @default.
• W2050362026 hasPublicationYear "2014" @default.
• W2050362026 type Work @default.
• W2050362026 sameAs 2050362026 @default.
• W2050362026 citedByCount "10" @default.
• W2050362026 countsByYear W20503620262015 @default.
• W2050362026 countsByYear W20503620262016 @default.
• W2050362026 countsByYear W20503620262019 @default.
• W2050362026 countsByYear W20503620262020 @default.
• W2050362026 countsByYear W20503620262021 @default.
• W2050362026 countsByYear W20503620262022 @default.
• W2050362026 countsByYear W20503620262023 @default.
• W2050362026 crossrefType "journal-article" @default.
• W2050362026 hasAuthorship W2050362026A5014785853 @default.
• W2050362026 hasAuthorship W2050362026A5025171057 @default.
• W2050362026 hasAuthorship W2050362026A5035959084 @default.
• W2050362026 hasAuthorship W2050362026A5042491943 @default.
• W2050362026 hasAuthorship W2050362026A5073839222 @default.
• W2050362026 hasAuthorship W2050362026A5074510658 @default.
• W2050362026 hasAuthorship W2050362026A5077131800 @default.
• W2050362026 hasAuthorship W2050362026A5080036669 @default.
• W2050362026 hasAuthorship W2050362026A5087552309 @default.
• W2050362026 hasBestOaLocation W20503620261 @default.
• W2050362026 hasConcept C109650736 @default.
• W2050362026 hasConcept C126322002 @default.
• W2050362026 hasConcept C128057223 @default.
• W2050362026 hasConcept C140840227 @default.
• W2050362026 hasConcept C197934379 @default.
• W2050362026 hasConcept C2777498785 @default.
• W2050362026 hasConcept C2778204628 @default.
• W2050362026 hasConcept C2778715759 @default.
• W2050362026 hasConcept C2779116819 @default.
• W2050362026 hasConcept C2781025758 @default.
• W2050362026 hasConcept C2909675724 @default.
• W2050362026 hasConcept C2911091166 @default.
• W2050362026 hasConcept C526171541 @default.
• W2050362026 hasConcept C62231903 @default.
• W2050362026 hasConcept C71924100 @default.
• W2050362026 hasConcept C90924648 @default.
• W2050362026 hasConcept C98274493 @default.
• W2050362026 hasConceptScore W2050362026C109650736 @default.
• W2050362026 hasConceptScore W2050362026C126322002 @default.
• W2050362026 hasConceptScore W2050362026C128057223 @default.
• W2050362026 hasConceptScore W2050362026C140840227 @default.
• W2050362026 hasConceptScore W2050362026C197934379 @default.
• W2050362026 hasConceptScore W2050362026C2777498785 @default.
• W2050362026 hasConceptScore W2050362026C2778204628 @default.
• W2050362026 hasConceptScore W2050362026C2778715759 @default.
• W2050362026 hasConceptScore W2050362026C2779116819 @default.
• W2050362026 hasConceptScore W2050362026C2781025758 @default.
• W2050362026 hasConceptScore W2050362026C2909675724 @default.
• W2050362026 hasConceptScore W2050362026C2911091166 @default.
• W2050362026 hasConceptScore W2050362026C526171541 @default.
• W2050362026 hasConceptScore W2050362026C62231903 @default.
• W2050362026 hasConceptScore W2050362026C71924100 @default.
• W2050362026 hasConceptScore W2050362026C90924648 @default.
• W2050362026 hasConceptScore W2050362026C98274493 @default.
• W2050362026 hasIssue "13" @default.
• W2050362026 hasLocation W20503620261 @default.
• W2050362026 hasLocation W20503620262 @default.
• W2050362026 hasOpenAccess W2050362026 @default.
• W2050362026 hasPrimaryLocation W20503620261 @default.
• W2050362026 hasRelatedWork W1504967983 @default.
• W2050362026 hasRelatedWork W1604849279 @default.
• W2050362026 hasRelatedWork W1965458832 @default.
• W2050362026 hasRelatedWork W2043837966 @default.
• W2050362026 hasRelatedWork W2163478143 @default.
• W2050362026 hasRelatedWork W2373134913 @default.
• W2050362026 hasRelatedWork W2406828499 @default.
• W2050362026 hasRelatedWork W2742772809 @default.
• W2050362026 hasRelatedWork W3117825493 @default.
• W2050362026 hasRelatedWork W4386062745 @default.
• W2050362026 hasVolume "53" @default.
• W2050362026 isParatext "false" @default.
• W2050362026 isRetracted "false" @default.

• next